RxDoctor Payments Data

Steven Stewart, MD

Family Medicine · Tucker, GANPI 1679579643

Payments from drug & device makers

$1,044in general payments, 2019–2025

Across 51 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$308
  • Novo Nordisk$218
  • Exact Sciences$82
  • Phathom Pharmaceuticals, Inc.$66
  • Esperion Therapeutics, Inc.$58
  • GSK$54
  • plus $258 from 12 others

What the payments were for

  • Food & beverage$1,044100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,044 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$80,528
Medicare patients
153
Services billed
774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$110,661
EliquisApixaban86$79,500
MounjaroTirzepatide46$53,315
JanuviaSitagliptin Phosphate21$29,648
FarxigaDapagliflozin Propanediol25$20,849
XareltoRivaroxaban16$17,105
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$16,215
JardianceEmpagliflozin17$13,654
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$9,285
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$6,430
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$6,054
Dexlansoprazole DrDexlansoprazole13$5,629
Albuterol Sulfate HfaAlbuterol Sulfate98$3,742
Nifedipine ErNifedipine93$2,933
Atorvastatin Calcium451$2,844

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$218$110,661103 claims
Lilly USA, LLCMounjaro$308$53,31546 claims
AstraZenecaFarxiga$16$20,84925 claims
Johnson & JohnsonXarelto$48$17,10516 claims
GSKTrelegy Ellipta$54$16,21514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Tucker

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →